Journal Title：Current Vascular Pharmacology

Current Vascular Pharmacology publishes clinical and research-based reviews/mini-reviews, original research articles, letters, debates, drug clinical trial studies and guest edited issues to update all those concerned with the treatment of vascular disease, bridging the gap between clinical practice and ongoing research.

Vascular disease is the commonest cause of death in Westernized countries and its incidence is on the increase in developing countries. It follows that considerable research is directed at establishing effective treatment for acute vascular events. Long-term treatment has also received considerable attention (e.g. for symptomatic relief). Furthermore, effective prevention, whether primary or secondary, is backed by the findings of several landmark trials. Vascular disease is a complex field with primary care physicians and nurse practitioners as well as several specialties involved. The latter include cardiology, vascular and cardio thoracic surgery, general medicine, radiology, clinical pharmacology and neurology (stroke units).

Current Vascular Pharmacology 发表临床和基于研究的评论/小型评论、原创研究文章、信件、辩论、药物临床试验研究和客座编辑的问题，以更新所有与血管疾病治疗有关的人，弥合两者之间的差距临床实践和正在进行的研究。

血管疾病是西方国家最常见的死亡原因，其发病率在发展中国家呈上升趋势。因此，大量研究旨在为急性血管事件建立有效的治疗方法。长期治疗也受到了相当大的关注（例如缓解症状）。此外，有效的预防，无论是初级的还是次级的，都得到了几项具有里程碑意义的试验结果的支持。血管疾病是一个复杂的领域，涉及初级保健医生和执业护士以及多个专业。后者包括心脏病学、血管和心胸外科、普通医学、放射学、临床药理学和神经学（卒中单元）。